CLBS16
CLBS16-P02
Phase 2 mab terminated
Quick answer
CLBS16 for Coronary Microvascular Dysfunction is a Phase 2 program (mab) at LISATA THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Coronary Microvascular Dysfunction
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated